Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
OPCH 
Option Care Health Inc (OPCH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: OPCH (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $38.78
1 Year Target Price $38.78
| 6 | Strong Buy |
| 3 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -1.13% | Avg. Invested days 52 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.61B USD | Price to earnings Ratio 22.55 | 1Y Target Price 38.78 |
Price to earnings Ratio 22.55 | 1Y Target Price 38.78 | ||
Volume (30-day avg) 10 | Beta 0.79 | 52 Weeks Range 21.39 - 35.53 | Updated Date 08/15/2025 |
52 Weeks Range 21.39 - 35.53 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.26 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-07-29 | When Before Market | Estimate 0.3797 | Actual 0.41 |
Profitability
Profit Margin 3.93% | Operating Margin (TTM) 5.84% |
Management Effectiveness
Return on Assets (TTM) 6.2% | Return on Equity (TTM) 15.25% |
Valuation
Trailing PE 22.55 | Forward PE 19.05 | Enterprise Value 5640685626 | Price to Sales(TTM) 0.86 |
Enterprise Value 5640685626 | Price to Sales(TTM) 0.86 | ||
Enterprise Value to Revenue 1.05 | Enterprise Value to EBITDA 13.96 | Shares Outstanding 162295008 | Shares Floating 152929011 |
Shares Outstanding 162295008 | Shares Floating 152929011 | ||
Percent Insiders 0.7 | Percent Institutions 104.41 |
Upturn AI SWOT
Option Care Health Inc
Company Overview
History and Background
Option Care Health, Inc. was formed in 2015 after Walgreens sold its infusion services division to Madison Dearborn Partners. The company has grown through acquisitions and organic expansion to become a leading provider of home and alternate site infusion services.
Core Business Areas
- Infusion Therapy Services: Provides a range of infusion therapies for chronic and acute conditions, including anti-infectives, nutrition support, and immune globulin therapy. Services include clinical monitoring, patient education, and pharmacy services.
Leadership and Structure
John C. Rademacher serves as the Chief Executive Officer. The company has a board of directors and is organized into various functional departments, including clinical operations, pharmacy, sales, and finance.
Top Products and Market Share
Key Offerings
- Anti-Infective Therapy: Infusion therapy to treat bacterial, viral, and fungal infections. Competitors include home healthcare agencies and other infusion providers. Market share is difficult to pinpoint precisely due to the fragmented nature of the infusion therapy market, but Option Care Health is a leading player.
- Nutrition Support: Parenteral and enteral nutrition for patients unable to obtain adequate nutrition through oral intake. Competitors include Cardinal Health and other home infusion companies. Market share is similarly hard to define precisely, but Option Care Health is a major provider.
- Immune Globulin Therapy: IVIG and SCIG therapies for patients with immune deficiencies and autoimmune disorders. Competitors include CVS Health (Coram) and specialty pharmacies. Again, precise market share data is limited but Option Care Health is a large provider of these therapies.
Market Dynamics
Industry Overview
The home and alternate site infusion market is growing due to factors such as an aging population, increasing prevalence of chronic diseases, and a shift towards lower-cost care settings. The industry is also driven by advancements in infusion therapies and technology.
Positioning
Option Care Health is positioned as a leading independent provider of home and alternate site infusion services. Its competitive advantages include its national network of pharmacies and infusion centers, its clinical expertise, and its focus on patient outcomes.
Total Addressable Market (TAM)
The US home infusion therapy market size was valued at USD 20.72 billion in 2023 and is expected to reach USD 34.53 billion by 2032. Option Care Health is well positioned to capture a significant portion of this TAM.
Upturn SWOT Analysis
Strengths
- National network of pharmacies and infusion centers
- Strong clinical expertise
- Focus on patient outcomes
- Established relationships with payers and providers
- Experience in navigating complex reimbursement landscapes
Weaknesses
- Reliance on reimbursement rates from government and private payers
- Sensitivity to changes in healthcare regulations
- Potential for disruptions in supply chain
- Exposure to competition from other infusion providers
Opportunities
- Expanding the scope of services offered
- Entering new geographic markets
- Developing partnerships with other healthcare providers
- Leveraging technology to improve patient care and efficiency
- Increase in chronic conditions and home infusion demand
Threats
- Changes in reimbursement policies
- Increased competition from other infusion providers
- Economic downturns that could reduce healthcare spending
- Cybersecurity threats to patient data
- Drug shortages or price increases
Competitors and Market Share
Key Competitors
- CVS (CVS)
- Walgreens Boots Alliance (WBA)
- UnitedHealth Group (UNH)
Competitive Landscape
Option Care Health's advantages include its focus solely on infusion therapy, allowing for specialized expertise. Disadvantages compared to larger competitors like CVS and Walgreens include less brand recognition and potential resource constraints.
Major Acquisitions
BioMatrix Specialty Pharmacy
- Year: 2021
- Acquisition Price (USD millions): 300
- Strategic Rationale: Expanded Option Care Health's presence in the specialty pharmacy market and added new therapeutic capabilities.
Growth Trajectory and Initiatives
Historical Growth: Option Care Health has experienced significant growth in recent years, driven by acquisitions and organic expansion.
Future Projections: Analyst estimates suggest continued revenue growth and profitability improvements in the coming years.
Recent Initiatives: Recent initiatives include expanding into new therapeutic areas and enhancing its technology platform. Also expansion of clinical programs.
Summary
Option Care Health appears to be a strong player in the growing home infusion market. Its specialized expertise and national network are key strengths. Reimbursement pressures and competition remain potential risks. The company has been successful in growing via acquisitions and organic expansion.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings (10-K, 10-Q)
- Analyst reports
- Industry reports
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market share figures are estimates and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Option Care Health Inc
Exchange NASDAQ | Headquaters Bannockburn, IL, United States | ||
IPO Launch date 1996-08-15 | CEO, President & Director Mr. John C. Rademacher | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 8000 | Website https://www.optioncarehealth.com |
Full time employees 8000 | Website https://www.optioncarehealth.com | ||
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.